Seeking to rectify existing federal and state policies which prevent people with intellectual disabilities from…
Kate O’NeillJune 1, 2023
Pharmaceutical company Eli Lilly today announced results of a phase III clinical trial that proves…
Kate O’NeillMay 3, 2023
At the end of March, the US Food & Drug Administration approved Inspire’s Hypoglossal Nerve…
Kate O’NeillMarch 29, 2023
Each year, the Down syndrome community and our supporters – family, friends, businesses, organizations and…
Kate O’NeillMarch 21, 2023
March 21st is “Down Syndrome Awareness Day,” a day designated by the United Nations to…
Kate O’NeillMarch 17, 2023
Parent, advocate, and published author, Steve Friedman has used his family's recent experiences to help…
Kate O’NeillMarch 15, 2023
"Alzheimer's meds are here. But for the Down syndrome community, it's still the 1980s" by…
Kate O’NeillMarch 2, 2023
2/22/2023 (Burlington, MA) – Today the LuMind IDSC Foundation, a leading national Down syndrome research…
Kate O’NeillFebruary 23, 2023
On Friday, January 6, the U.S. Food & Drug Administration (FDA) granted accelerated approval for…
Kate O’NeillJanuary 10, 2023